Cochrane COVID-19 Study Register
IRCT20200324046850N3 // U07

The effect of naproxen on the healing process of patients with COVID-19

  1. Study Type
  2. Interventional
  1. Study Aim
  2. Treatment and Management
  1. Study Design
  2. Parallel/Crossover
  1. Intervention Assignment
  2. Randomised
  1. Population (9)
  2. Male and Female
  3. COVID-19
  4. Chest CT
  5. Adult
  6. Aged (65+)
  7. Child
  1. Intervention (3)
  2. Naproxen
  3. Lopinavir And Ritonavir
  4. Hydroxychloroquine Sulfate
  1. Comparison (3)
  2. Hydroxychloroquine Sulfate
  3. Lopinavir And Ritonavir
  4. Placebo
  1. Outcome (4)
  2. Cough
  3. Fever
  4. Night Sweats
  5. Chill

The effect of naproxen on the healing process of patients with COVID-19

IRCT20200324046850N3, U07
Trial registry record
No Results
Condition: corona virus disease. COVID-19, virus not identified;U07.2 Inclusion criteria: Having a chest CT scan to confirm Covid 19Having Clinical symptoms of covid 19 including fever, muscle pain, shortness of breath, dry cough, sore throat, runny noseConfirmation of covid19 by an infectious disease physicianHaving consent to participate in the intervention